Archive | August, 2015

Dr. Michael Har-Noy Will Soon Start A Phase II/III Trial In Colorectal Tumors

19 Aug

Dr. Michael Har-Noy plans tostart a pivotal Phase II/III randomized study of AlloStim TM in the therapyof metastatic KRAS gene positive colon tumors. Dr. Michael Har-Noy notes there is no approved third line treatment forthese patients.  A favorable outcome ofthis study would likely lead to FDA marketing approval for AlloStim TM.  Dr. Michael Har-Noy intends to start thestudy in the United States as well as two other international sites.

via Dr. Michael Har-Noy Will Soon Start A Phase II/III Trial In Colorectal Tumors.

Advertisements